当前位置:首页 - 行情中心 - 甘李药业(603087) - 财务分析 - 现金流量表

甘李药业

(603087)

  

流通市值:372.65亿  总市值:399.00亿
流通股本:5.58亿   总股本:5.97亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金2,799,253,112.311,844,216,752.72908,976,184.93,288,200,661.2
  收到的税费返还85,506,119.0644,572,971.940,666,316.1867,514,079.81
  收到其他与经营活动有关的现金75,818,636.5870,666,424.6467,079,616.1332,558,036.64
  经营活动现金流入小计2,960,577,867.951,959,456,149.261,016,722,117.213,388,272,777.65
  购买商品、接受劳务支付的现金725,969,731.03528,571,696.5261,817,120.26877,788,113.15
  支付给职工以及为职工支付的现金764,768,091.94529,804,354.61244,825,723.94868,551,344.92
  支付的各项税费237,385,212.17187,711,333.93103,046,569.52167,704,019.59
  支付其他与经营活动有关的现金750,494,376.24464,818,522.13248,286,436.72936,919,576.69
  经营活动现金流出小计2,478,617,411.381,710,905,907.17857,975,850.442,850,963,054.35
  经营活动产生的现金流量净额481,960,456.57248,550,242.09158,746,266.77537,309,723.3
二、投资活动产生的现金流量:
  收回投资收到的现金4,862,623,9703,100,430,2702,022,569,7708,766,979,387.42
  取得投资收益收到的现金79,501,731.7555,644,592.6834,674,396.0588,224,339.14
  处置固定资产、无形资产和其他长期资产收回的现金净额18,05618,056819,494.19-
  收到的其他与投资活动有关的现金---2,604,019.81
  投资活动现金流入小计4,942,143,757.753,156,092,918.682,058,063,660.248,857,807,746.37
  购建固定资产、无形资产和其他长期资产支付的现金627,863,920.32366,970,304.43157,871,020.42440,801,383.9
  投资支付的现金3,982,756,561.062,259,069,011.671,872,948,242.748,679,034,759.9
  投资活动现金流出小计4,610,620,481.382,626,039,316.12,030,819,263.169,119,836,143.8
  投资活动产生的现金流量净额331,523,276.37530,053,602.5827,244,397.08-262,028,397.43
三、筹资活动产生的现金流量:
  吸收投资收到的现金---139,321,600
  筹资活动现金流入平衡项目---0
  筹资活动现金流入小计---139,321,600
  分配股利、利润或偿付利息支付的现金597,197,899597,525,269-420,547,253
  支付其他与筹资活动有关的现金140,071,249.6135,819,147.0775,214,479.719,488,130
  筹资活动现金流出小计737,269,148.6733,344,416.0775,214,479.7440,035,383
  筹资活动产生的现金流量净额-737,269,148.6-733,344,416.07-75,214,479.7-300,713,783
四、汇率变动对现金及现金等价物的影响2,686,658.893,302,350.071,466,877.94-951,386.7
五、现金及现金等价物净增加额78,901,243.2348,561,778.67112,243,062.09-26,383,843.83
  加:期初现金及现金等价物余额260,055,136.76260,055,136.76260,055,136.76286,438,980.59
  期末现金及现金等价物余额338,956,379.99308,616,915.43372,298,198.85260,055,136.76
补充资料:
  净利润-603,680,572.48-614,663,800.7
  资产减值准备--18,215.12-15,656,632.99
  固定资产和投资性房地产折旧-132,680,148.88-240,956,510.52
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-132,680,148.88-240,956,510.52
  无形资产摊销-9,269,121.11-15,073,711.59
  长期待摊费用摊销-884,377.08-1,768,304.77
  处置固定资产、无形资产和其他长期资产的损失----1,866,209.36
  固定资产报废损失-107,351.01-711,631.62
  公允价值变动损失--64,965,330.59--156,612,377.87
  财务费用--48,205,553.83--90,764,224.8
  投资损失--7,356,114.57--61,249,137.11
  递延所得税--20,390,658.37--28,565,809.8
  其中:递延所得税资产减少--13,330,978.7--40,676,561.32
    递延所得税负债增加--7,059,679.67-12,110,751.52
  存货的减少--121,169,652.02--203,039,601.32
  经营性应收项目的减少--506,000,735.9-132,153,044.31
  经营性应付项目的增加-229,370,078.69--37,493,974.76
  其他-38,824,093.87-112,851,523.53
  不涉及现金收支的投资和筹资活动金额其他项目-5,081,623.23-19,394,709.27
  现金的期末余额-308,616,915.43-260,055,136.76
  减:现金的期初余额-260,055,136.76-286,438,980.59
  现金及现金等价物的净增加额-48,561,778.67--26,383,843.83
公告日期2025-10-312025-08-082025-04-252025-04-25
审计意见(境内)标准无保留意见
TOP↑